ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$XENE:NASDAQ · Xenon Pharmaceuticals Inc - US

Sector: health

Conviction from: NASDAQ

52-week range: 33.3872.66

Neurology-focused biopharma (epilepsy, depression)

2 tracked filer(s) hold this · 0 opened, 1 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 68 — mean of 2 scored holder(s) · buyers (new/add) avg 75. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Steve Cohen / Point7275Added +813%1,190,201$44,263,5750.0%
Paul Tudor Jones / Tudor61Trimmed -95%24,783$921,6800.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-10-01MORTIMER IAN (cluster of 2)director+officer30,000$1,121,400Form 4
2026-10-01Kelly Thomas Patrick (cluster of 2)officer15,000$559,740Form 4

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.